2-(4-((5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino)butoxy)acetic acid
Properties
- Molecular formula
- C25H29N3O3
- Molar mass
- 419.53 g/mol
- Exact mass
- 419.2209 Da
- logP
- 4.91Crippen estimate
- Polar surface area
- 75.5 Ų
- H-bond donors / acceptors
- 1 / 5
- Rotatable bonds
- 11
Hazards
Warning
- H302 Harmful if swallowed100% of notifiers
Aggregated from the ECHA notifications, via PubChem; a share says how many notifiers assign that statement.
Precautionary statements
P264, P270, P301+P317, P330, P501
Identifiers
CAS number
475085-57-5SMILES
CC(C)N(CCCCOCC(=O)O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1InChIKey
OJQMKCBWYCWFPU-UHFFFAOYSA-NInChI
InChI=1S/C25H29N3O3/c1-19(2)28(15-9-10-16-31-18-23(29)30)22-17-26-24(20-11-5-3-6-12-20)25(27-22)21-13-7-4-8-14-21/h3-8,11-14,17,19H,9-10,15-16,18H2,1-2H3,(H,29,30)Characterization data
Calculated from the structure, in the form journals print them.
¹H NMR
Predicted ¹H NMR (400 MHz, CDCl₃) δ 11.50 (br s, 1H), 8.23 (s, 1H), 7.73 (dd, J = 7.7, 1.6 Hz, 2H), 7.73 (dd, J = 7.7, 1.6 Hz, 2H), 7.56 (m, J = 7.7 Hz, 2H), 7.56 (m, J = 7.7 Hz, 2H), 7.46 (m, J = 7.7, 1.6 Hz, 1H), 7.46 (m, J = 7.7, 1.6 Hz, 1H), 4.34 (s, 2H), 3.60 (sept, J = 7.0 Hz, 1H), 3.45 (t, J = 7.0 Hz, 2H), 3.20 (t, J = 7.0 Hz, 2H), 1.63 (m, J = 7.0 Hz, 2H), 1.60 (m, J = 7.0 Hz, 2H), 1.22 (d, J = 7.0 Hz, 6H).¹³C NMR
Predicted ¹³C NMR (101 MHz, CDCl₃) δ 177.0, 167.1, 157.9, 145.3, 141.4, 141.4, 129.0, 128.9, 128.9, 127.4, 127.4, 127.3, 127.3, 72.1, 71.0, 51.4, 46.7, 28.8, 28.1, 24.2.[M + H]+
[M + H]+ Calcd for C25H30N3O3 420.2282[M + Na]+
[M + Na]+ Calcd for C25H29N3NaO3 442.2101[M − H]−
[M − H]− Calcd for C25H28N3O3 418.2136Elemental analysis
Anal. Calcd for C25H29N3O3: C, 71.57; H, 6.97; N, 10.02.Weigh it out
Type any one amount. The others follow from the molar mass.
Names and synonyms
8 names
- 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]acetic acid
- Acetic acid, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-
- Acetic acid, [4-[(5,6-diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-
- MRE 269
- ACT 333679
- [4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]acetic acid
- 2-[4-[(5,6-Diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy]acetic acid
- 2-(4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid
Work with 2-(4-((5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino)butoxy)acetic acid
Similar compounds
2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide475086-01-269 % similar
4-((5,6-Diphenyl-Pyrazin-2-yl)(isopropyl)amino)butan-1-ol475086-75-063 % similar
Polyethylene glycol carboxymethyl lauryl ether sodium salt33939-64-936 % similar
(-)-Cetirizine130018-77-835 % similar
Cetirizine83881-51-035 % similar
(Benzyloxy)acetic acid30379-55-635 % similar
Butoxyacetic acid2516-93-034 % similar
2-(4-Phenylphenoxy)acetic acid13333-86-334 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.